Happify Health is launching its first prescription digital therapeutic (PDTx), called Ensemble, which will focus on treating Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD).
Happify Health has launched a digital therapeutic designed to help diagnose and manage major depressive disorder as well as generalized anxiety disorder, as the two conditions often go hand-in-hand.
Happify Inc. launched Ensemble, a prescription digital therapy designed to treat patients with major depressive disorder (MDD) or generalized anxiety disorder (GAD). The app joins several others that ...
NEW YORK--(BUSINESS WIRE)--Today, Happify Health (www.HappifyHealth.com), the Intelligent Healing Company, announced findings from a real-world data analysis exploring the impact of Happify for users ...
Happify is taking advantage of relaxed FDA rules to release a prescription-only app for treating people with both major depressive disorder and generalized anxiety disorder. The app, called Ensemble, ...
You probably wouldn't think of chugging a glass of water, or talking to another person as "power-ups," but app SuperBetter is reframing mental health upkeep as a game. Anxiety disorders are the most ...
NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Happify Health, a global leader in mental health technology, today announced it signed an agreement with global biopharmaceutical company Sanofi (NASDAQ: SNY) ...
NEW YORK--(BUSINESS WIRE)--Today, leading digital mental health company, Happify Health, announced the availability of a variety of free resources to help people manage stress and worry amidst the ...
Happify Inc. launched Ensemble, a prescription digital therapy designed to treat patients with major depressive disorder (MDD) or generalized anxiety disorder (GAD). The app joins several others that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results